Clinical Trial Update: ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects in a Phase Ⅱ Clinical Trial [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for ZKY001 eye drops in corneal epithelial defects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Epithelial Defect

Drugs mentioned

• ZKY001

Snippet

Sponsor: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. | Conditions: Corneal Epithelial Defect | Phase 2 | Status: COMPLETED